Left ventricular (LV) diastolic function assessed by tissue Doppler imaging (TDI) is reported to be associated with left atrial (LA) blood stasis in patients with non-valvular atrial fibrillation (AF). This study aimed to evaluate the relationship of diastolic TDI parameters with silent brain infarction (SBI) on brain magnetic resonance imaging (MRI), and in turn the risks of subsequent stroke or dementia, in non-valvular AF patients. 
Introduction
Non-valvular atrial fibrillation (AF) is the most common cause of symptomatic cardioembolic stroke. In addition, silent brain infarction (SBI) is also frequently seen in patients with non-valvular AF. 1 Because SBI is a major risk factor for subsequent symptomatic stroke 2 and dementia, [3] [4] [5] [6] it is important to clarify the risk of SBI when managing AF patients. As with symptomatic cardioembolic stroke, the main mechanism of SBI is understood to be thrombus formation in the fibrillating left atrium. 3, 4 Our group previously reported parameters on transoesophageal echocardiography (TOE), i.e. left atrial (LA) abnormalities such as LA thrombus, spontaneous echo contrast (SEC), or low LA appendage (LAA) emptying velocity, to be independent predictors of SBI. 7 However, as TOE is semiinvasive and not readily performed in low-risk patients with AF, non-invasive parameters assessed by transthoracic echocardiography are expected to serve as the primary means of risk stratification for SBI.
Impaired left ventricular (LV) diastolic function and consequent elevation of LV diastolic filling pressure can lead to LA blood stasis which results in thrombus formation within left atrium. 8, 9 The ratio of early transmitral flow velocity (E) and mitral annular velocity during diastole (e 0 ), determined by tissue Doppler imaging (TDI) (E/e 0 ), has been widely used to estimate of LV diastolic filling pressures in patients with various heart diseases 10 and also in those with AF. 11, 12 Several studies have shown the relationship between an increased E/ e 0 ratio and LA abnormalities detected by TOE which exacerbate LA thrombus formation in AF patients. 8, 9 We hypothesized that the E/e 0 ratio determined by TDI could be a useful parameter for identifying high-risk patients with SBI. In this study, therefore, we assessed whether E/e 0 ratio based on TDI measurements is associated with the presence of SBI on brain magnetic resonance imaging (MRI) in neurologically asymptomatic patients with non-valvular AF.
Methods

Study population
In this prospective study, we recruited 207 consecutive neurologically asymptomatic patients with non-valvular AF who were scheduled to undergo TOE for the assessment of LA thrombus prior to transcatheter AF ablation in Osaka City University Hospital. We excluded 26 patients who had a history of previous transcatheter AF ablation and 10 patients refused brain MRI. There was no patient with clinically evidence of previous embolism in our study population. The final study group was thus comprised 171 patients (128 men; mean age, 63 6 11 years) who underwent TOE and were screened for SBI by brain MRI. The study protocol was approved by our hospital's ethics committee, and written informed consent was obtained from each patient.
Clinical variables
Information on clinical variables including risk factors such as age, gender, hypertension, diabetes mellitus, hypercholesterolaemia, smoking status, and history of congestive heart failure or stroke was collected for each patient. Hypertension was defined as a systolic blood pressure !140 mmHg or a diastolic blood pressure !90 mmHg based on two separate measurements, a patient's self-report of hypertension history, or the use of antihypertensive medications. Diabetes mellitus was determined by the presence of an existing diagnosis, a fasting blood glucose level !126 mg/dL, a glycohaemoglobin A1c level !6.5% as defined by the Japan Diabetes Society, 13 or the use of antidiabetic medications or insulin.
Hypercholesterolaemia was defined as a serum cholesterol value !220 mg/dL or a low-density lipoprotein cholesterol value !140 mg/ dL according to the Japan Atherosclerosis Society 2007 guidelines, 14 or the use of cholesterol-lowering medication. Patients were classified as non-smokers if they had never smoked or if they had stopped smoking !10 years before the study. All other patients were classified as smokers. The estimated glomerular filtration rate (eGFR) was calculated as 0. 17 Information regarding the use of medications such as anticoagulants, statins, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and antiarrhythmic therapy was also obtained.
Transoesophageal echocardiographic analysis
We performed TOE 1 or 2 days prior to AF ablation, using a commercially available ultrasound imaging system (iE33, Philips Medical Systems, Andover, MA, USA) with a 3D matrix-array transoesophageal transducer (X7-2t). LA abnormalities such as thrombi in the LA, SEC, or abnormal LAA emptying velocity were assessed by TOE in all patients. SEC was defined as a dynamic smoke-like signal that swirled slowly in a circular pattern within the LA and appendage, with appropriate gain settings to distinguish SEC from echoes due to excessive gain ( Figure 1B) . 18, 19 For assessment of LAA emptying velocity, 10 consecutive pulsed-wave Doppler outflow velocity signals during diastole were measured 1 cm below the orifice of the LAA over at least three cardiac cycles and averaged. LAA emptying velocity <20 cm/s was considered to be abnormal. 20 The method used to evaluate aortic arch plaques by TOE has been described in previous publications. 7, 21, 22 We evaluated the presence, thickness, and characteristics of aortic plaques in the aortic arch. Complex plaques were defined as large plaques (!4 mm in thickness), plaques with ulceration, or plaques with mobile components.
Transthoracic echocardiographic analysis
Transthoracic echocardiography was performed on the same day as TOE using a commercially available ultrasound imaging system, and standard 2D and Doppler images were acquired in the parasternal and apical views. Using the pulse wave Doppler method, the peak velocity of diastolic early transmitral Doppler flow (E) was measured by placing a sample volume at the opening levels of the mitral valve leaflet tips Figure 1C .
Tissue Doppler velocity during early diastole (e 0 ) was measured from the septal corner of the mitral annulus in the apical four-chamber view ( Figure  1D ). Doppler measurements were obtained by averaging data from three consecutive cardiac cycles in the case of sinus rhythm and from five consecutive cardiac cycles in the case of AF rhythm, and E/e 0 ratios were calculated. The diastolic measurements of LV end-diastolic dimension (LVDd), interventricular septal wall thickness (IVS), and posterior wall thickness (PW) (in mm) were used to calculate LV mass (LVM) using the formula recommended:
]} þ 0.6 g. 23 LA volume was measured using the biplane Simpson method in the apical four-and two-chamber views. LVM and LA volume measurements were indexed to body surface area.
Brain MRI
We performed brain MRI within 1 month before AF ablation. The method of evaluating SBI by brain MRI was described in detail in a previous publication. 7 Brain MRI was performed using a superconducting magnet at a field strength of 1.5 or 3.0 T on proton density, T1-and T2-weighted images, and fluid-attenuated inversion recovery (FLAIR) images in axial planes with 5 mm-in-thickness slices and an interslice gap of 1.5 mm. SBI was defined as an area of hypointense lesions that measured >3 mm on T1-weighted images and hyperintense lesions on T2-weighted images ( Figure 1A ). FLAIR images were used to separate dilated Virchow-Robin spaces from infarcts based on the absence or presence of a hyperintense rim around each of the suspected lesions. Lesions lacking a hyperintense rim on FLAIR were considered to be dilated VirchowRobin spaces. MRIs were analysed independently by two neuroradiologists who had not been informed of the clinical information. The joint agreement was 93% (Kappa ¼ 0.83), and conflicts were resolved by common agreement.
Statistical analysis
The results are expressed as means 6 SD. When two groups were compared, the unpaired t-test or Mann-Whitney U test was used, as Fisher's exact test. Statistical comparisons among the three groups were performed using one-way analysis of variance, and post hoc multiple comparisons were conducted using Scheffe's test. The association of the E/e 0 ratio with the presence of SBI on brain MRI was evaluated by multiple logistic regression analysis after adjustment for significant variables with P < 0.01 on univariate analysis. Ages were entered into the regression analysis as continuous variables. P-values <0.05 were considered to indicate a statistically significant association.
Results
Clinical characteristics and the presence of SBI
Clinical characteristics of 171 patients with non-valvular AF are shown in Table 1 . Of these patients, 76 (44%) had persistent AF. Oral anticoagulation was newly started in 72 patients prior to AF ablation procedures (42%) [69 patients with non-vitamin K antagonist oral anticoagulants (96%) and three with warfarin (4%)], and the remaining 99 patients were treated with continuous anticoagulation (58%) [65 patients with non-vitamin K antagonist oral anticoagulants (66%) and 34 with warfarin (34%)].
Of the 171 patients, 47 (27%) showed SBI on brain MRI. All patients with SBI underwent ultrasound carotid assessment, and no significant stenosis was found in the carotid arteries in those patients. The characteristics of patients in whom SBI were detected and those free of SBI are also shown in Table 1 . Patients with SBI were older (P < 0.001), and had higher prevalences of hypertension (P ¼ 0.007), diabetes mellitus (P ¼ 0.010), and persistent AF (P ¼ 0.039) than those without SBI. eGFR was significantly lower (P ¼ 0.002) and both the CHADS 2 scores (P < 0.001) and the CHA 2 DS 2 -VASc scores (P < 0.001) were higher in patients with SBI than in those without SBI.
Echocardiographic characteristics and the presence of SBI
Echocardiographic data for all patients are shown in Table 2 . Conventional echocardiographic examination demonstrated that there were no significant differences in LV end-diastolic and endsystolic dimension, LV ejection fraction, LV wall thickness (IVS and PW), LVM index, LA diameter, and the LA volume index between the two groups. Patients with SBI had significantly higher E-wave velocities on transmitral Doppler flow (81 6 26 vs. 70 6 18 cm/s; P ¼ 0.003) and lower e 0 velocities on TDI (6.3 6 1.7 vs. 7.3 6 2.1 cm/s; P ¼ 0.003) than those without SBI. Consequently, the E/e 0 ratio was higher in patients with SBI than in those without SBI (13.6 6 5.6 vs. 10.1 6 3.2; P < 0.001). As to TOE parameters, patients with SBI had higher prevalences of SEC (P < 0.001) and complex arch plaques (P ¼ 0.003), and a lower LAA emptying velocity (P ¼ 0.005) than those without SBI.
E/e 0 ratio and transoesophageal echocardiographic parameters
We divided the study patients into three groups based on the tertile of the E/e 0 ratio (the lowest tertile: <9.0, the intermediate tertile:
9.0-12.1, the highest tertile: >12.1). An increased tertile of the E/e 0 ratio was significantly associated with a high prevalence of LA abnormalities (P ¼0.002) and decreased LAA velocity (P < 0.001) (Figure 2) . Patients with the highest tertile of E/e 0 had a significantly higher prevalence of LA abnormalities than those with the intermediate (P ¼ 0.023) or the lowest tertile of the E/e 0 ratio (P ¼ 0.005) (32% vs. 12% vs. 9%), and they had a lower LAA emptying velocity than those with the intermediate or the lowest tertile of E/e 0 (P < 0.001 for both) ( Figure 2 ). No significant relationship was observed between an increased tertile of the E/e 0 ratio and a high prevalence of complex arch plaques (21% vs. 19% vs. 7%) (P ¼ 0.082)
E/e 0 ratio and the presence of SBI
The increased tertile of E/e 0 was related to a high prevalence of SBI (P < 0.001), and SBI was found more frequently in patients with the highest tertile of the E/e 0 ratio than in those with the intermediate (P ¼ 0.020) or the lowest tertile (P < 0.001) (46% vs. 23% vs. 14%) ( Figure 3) . The receiver operating characteristic (ROC) curve analysis demonstrated that 12.4 was the optimal cut-off value of E/e 0 for predicting SBI (area under the curve 0.72) with 55% sensitivity and 80% specificity (Figure 4 ). In the univariate logistic regression analysis, age (P < 0.001), hypertension (P ¼ 0.008), CKD (P < 0.001), CHADS 2 score ! 2 (P < 0.001), CHA 2 DS 2 -VASc score ! 2 (P < 0.001), and E/e 0 ratio ! 12.4 (OR
Figure 2 Prevalences of SBI according to tertiles of the E/e
0 ratio in non-valvular AF patients. An increased tertile of E/e 0 was associated with a high prevalence of SBI (P < 0.001). Patients with the highest tertile of E/e 0 had a significantly higher prevalence of SBI than those with the intermediate (**P ¼ 0.020 vs. the highest tertile) or the lowest tertile of E/e 0 (*P < 0.001 vs. the highest tertile).
Figure 3 Prevalences of LA abnormalities by TOE (left) and LAA emptying velocity (right) according to the tertiles of the E/e
0 ratio in non-valvular AF patients. An increased tertile of E/e 0 was associated with a high prevalence of LA abnormalities (P ¼ 0.002) and decreased LAA velocity (P < 0.001). Patients with the highest tertile of E/e 0 had a significantly higher prevalence of LA abnormalities by TOE (*P ¼ 0.005; ** P ¼ 0.023 vs. the highest tertile) and lower LAA velocity (*P < 0.001; **P < 0.001 vs. the highest tertile) than those with the intermediate or the lowest tertile of the E/e 0 ratio. 4.90, 95% CI 2.38-10.11; P < 0.001) were strong non-invasive predictors of the presence of SBI (P < 0.01) ( Table 3 ). E/e 0 ratio !12.4
was significantly associated with SBI independent of hypertension status by binary logistic regression analysis (OR 4.92, 95% CI 2.24-10.83; P < 0.001). Moreover, multivariate logistic regression analysis after adjustment for age, hypertension, CKD, and CHA 2 DS 2 -VASc score !2 revealed E/e 0 ratio !12.4 to be an independent predictor of SBI (OR 3.98, 95% CI 1.74-9.07; P ¼ 0.001) ( Table 3 ).
In addition, we evaluated the relationship between E/e 0 and SBI according to types of AF. E/e 0 ratio was significantly higher in patients with SBI than in those without SBI in both persistent AF group (14.9 6 6.4 vs. 11.0 6 3.9; P < 0.001) and paroxysmal AF group (11.9 6 3.9 vs. 9.6 6 2. 
Discussion
To the best of our knowledge, this is the first study demonstrating the relationship between diastolic TDI assessment and silent stroke based on brain MRI in patients with non-valvular AF. In this study, we confirmed an increased E/e 0 ratio, as assessed by TDI, to be associated with a higher prevalence of LA abnormalities detected by TOE, and found that this parameter is independently associated with SBI on brain MRI after adjustment for significant risk factors including age and CHA 2 DS 2 -VASc score !2. TOE is a gold standard for detecting cardiogenic thromboembolic sources and the risks of thromboembolism such as LA abnormalities in AF patients. 12, 24 As a non-invasive parameter determined by transthoracic echocardiography, the E/e 0 ratio not only reflects LV relaxation but also serves as a measure of LV filling pressure. 10 Previously, Iwakura et al. 8 showed the E/e 0 ratio to be negatively associated with LAA flow velocity and positively associated with the rate of SEC, as assessed by TOE, in patients with paroxysmal or persistent nonvalvular AF, and showed the E/e 0 ratio !13 to be an independent predictor of LAA thrombus in these patients. Very recently, Doukky et al. 9 prospectively demonstrated that the E/e 0 ratio and e 0 velocity can predict LAA thrombus or LAA sludge, as assessed by TOE, independently of clinical parameters including the CHA 2 DS 2 -VASc score. Our observation that the prevalence of LA abnormalities, detected by TOE, was significantly higher in patients with the highest tertile of the E/e 0 ratio is consistent with these findings in previous studies. This can be explained by the concept that an increased E/e 0 ratio represents elevated LV diastolic filling pressure and consequently LA blood stasis, which leads to the formation of SEC or LAA thrombus. 8, 9 We previously reported LA abnormalities, detected by TOE, to be an independent predictor of SBI independent of CHADS 2 score-!2.
7 Despite the close correlation between an increased E/e 0 ratio and TOE-detected LA abnormalities in AF patients, 8, 9 few studies have focused on the associations of diastolic TDI parameters with cerebrovascular events. Only a cross-sectional study of 330 patients with persistent AF, by Lee et al., 25 showed that the E/e 0 ratio and hypertension were independently associated with a history of symptomatic ischaemic stroke. However, no studies have investigated the relationship between the E/e 0 ratio and brain infarcts on brain MRI in neurologically asymptomatic patients with AF. In our study, age, hypertension, CKD, the CHADS 2 score !2, the CHA 2 DS 2 -VASc score !2, and an increased E/e 0 ratio were major non-invasive risk factors for SBI (all valued of P < 0.01). Previous studies demonstrated that increasing age was the only clinical risk factor consistently associated with SBI in AF patients. 7 Additionally, it is well known that the CHA 2 DS 2 -VASc score is linked to an increasing risk of cerebrovascular events. 17, 26, 27 Currently, the CHA 2 DS 2 -VASc score !2 is the most commonly used method of stroke and thromboembolic risk stratification in patients with non-valvular AF. 26, 27 Except for LV impairment or aortic plaques on echocardiography, however, the CHA 2 DS 2 -VASc score does not include any imaging parameters. 28 The ROC curve analysis in this study demonstrated that E/e 0 !12.4
could predict the presence of SBI with relatively high specificity (80%), and our multivariate analysis showed the E/e 0 ratio !12.4 to be an independent parameter predicting SBI after adjustment for major risk factors including the CHA 2 DS 2 -VASc score !2. These findings suggest that an increased E/e 0 ratio might be considered as high risk even in patients with low CHA 2 DS 2 -VASc score, and it could play a complementary role to CHA 2 DS 2 -VASc score in predicting thromboembolic risk. Recent advances in brain MRI have enhanced the accuracy of information on ischaemic cerebral injury or damage. 29 SBI can be regarded as the early stage of brain infarction, thereby providing direct evidence of a high risk of symptomatic stroke. 2 Furthermore, recent studies have focused on the relationship between AF and cognitive impairment, [3] [4] [5] [6] 30 and possible mechanisms underlying the increased risk of dementia risk in AF patients with SBI and the cerebral damage caused by microembolization. [3] [4] [5] [6] 31 Our findings suggest that, in addition to LA abnormalities detected by TOE, high LV filling pressure revealed by TDI is a significant risk factor for SBI in AF patients, and the E/e 0 ratio can serve as non-invasive and alternative index to TOEdetected LA abnormalities for risk stratification of stroke or dementia in AF patients. However, it is difficult to establish cause and effect of the relationship between increased E/e 0 and SBI or AF. It is possible those who develop SBI may have a generalized vascular disorder that increases their risk of cardiac hypertrophy and therefore increased E/ e 0 which increases the risk of them developing AF. Therefore, a prospective follow-up studies are still needed to ascertain whether the E/e 0 ratio is a predictor of cerebrovascular events and/or dementia, and whether anticoagulation reduces the risk of SBI, as well as those of cognitive impairment and dementia, in AF patients.
Study limitations
Our study subjects were limited to patients scheduled to undergo transcatheter AF ablation, and the majority of study population was male. Further studies are necessary to determine whether our results might be extended to the general population with AF. In this study, there was no difference in the prevalence of the use of continuous anticoagulation between patients with SBI and those without it. This may be due to small number of study population, and may show that the effective period of anticoagulation therapy during exposure to AF is a more important determinant for the occurrence of SBI. However, complete data on the duration of AF and anticoagulant treatment as well as the adequacy of anticoagulation, which may affect the presence of SBI on brain MRI, were not available for all study subjects. E/e 0 was calculated using only septal e 0 , not average e 0 (septal and lateral) in the present study. Also, Doppler measurements were obtained by averaging data only from five consecutive cardiac cycles in the case of AF rhythm. However, the average of Doppler measurements from 10 cardiac cycles may be the most accurate because Doppler evaluation of LV diastolic function is limited by the increased variability in cycle length in AF patients. 10, 12 The presence of silent brain infarcts does not necessarily imply that they are related to the AF. Complex arch plaques on TOE have been reported to be an important embolic source of brain infarcts, 7 and, in this study, patients with SBI had a higher prevalence of complex arch plaques than those without SBI. Moreover, other factors such as old myocardial infarction, dilated cardiomyopathy, or carotid disease may influence the presence of SBI. In our study, however, the relationship between these factors and SBI could not be evaluated because of low prevalences of these conditions. Data regarding biomarkers such as serum BNP levels or second brain MRI for follow-up to see who develops new infarcts were lacking. In addition, automated quantification of number and volume of infarcts on brain MRI was not available in this study. Finally, this study was lacking of control group who did not have AF. These issues should be addressed in future research.
Conclusion
In patients with non-valvular AF, impaired LV diastolic function and consequent increased LV diastolic filling pressure evaluated by the E/e 0 ratio were found to be closely associated with the presence of SBI independent of confounding risk factors and CHA 2 DS 2 -VASc score. TDI measurements are non-invasive and useful for risk stratification of the early stage of cerebral damages, and could be additional risk factors of thromboembolism in patients with lower CHA 2 DS 2 -VASc score.
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